KRAS and cancer: To verify whether the expression of the signature of the 3 genes - RUVBL1, HSPA9, and XPO1 - which encode the proteins targeted in Fig. 3 is indeed associated with the presence of mutant p53, mutant KRAS, or high levels of c-Myc, we interrogated cancer patient samples.